Giriraj Herbals (India) Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 10-12-2024
- Paid Up Capital ₹ 0.10 M
as on 10-12-2024
- Company Age 19 Year, 10 Months
- Last Filing with ROC 31 Mar 2012
- Satisfied Charges ₹ 1.82 M
as on 10-12-2024
About Giriraj Herbals (India)
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2012. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹1.82 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Suvankar Adhikari, Kondaka Rao, Hemlata Ottala, and One other member serve as directors at the Company.
- CIN/LLPIN
U24239WB2005PTC102078
- Company No.
102078
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Mar 2005
- Date of AGM
29 Sep 2012
- Date of Balance Sheet
31 Mar 2012
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Giriraj Herbals (India)?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suvankar Adhikari  | Director | 17-Nov-2011 | Current |
| Kondaka Rao | Director | 17-Nov-2011 | Current |
| Hemlata Ottala | Director | 04-Mar-2014 | Current |
| Jallapalli Sridevi | Additional Director | 29-May-2014 | Current |
Financial Performance of Giriraj Herbals (India).
Enhance accessibility to Giriraj Herbals (India)'s financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Giriraj Herbals (India)?
Unlock access to Giriraj Herbals (India)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Unimass Entertainments Private LimitedActive 13 years 14 daysSuvankar Adhikari and Kondaka Rao are mutual person
- Unimass Pharmaceuticals Private LimitedActive 13 years 6 months
Kondaka Rao and Hemlata Ottala are mutual person
Charges (Loans)
₹0
₹1.82 M
Charges Breakdown by Lending Institutions
- United Bank Of India : 0.18 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Aug 2005 | United Bank Of India | ₹1.82 M | Satisfied |
How Many Employees Work at Giriraj Herbals (India)?
Unlock and access historical data on people associated with Giriraj Herbals (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Giriraj Herbals (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Giriraj Herbals (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
